Kuros Biosciences AG

SWX:KURN 株式レポート

時価総額：CHF 783.4m

Kuros Biosciences マネジメント

マネジメント 基準チェック /24

Kuros Biosciencesの CEO はChris Fairで、 Oct2023年に任命され、 の在任期間は 1.17年です。 の年間総報酬はCHF 1.34Mで、 24.6%給与と75.4%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.35%を直接所有しており、その価値はCHF 2.78M 。経営陣と取締役会の平均在任期間はそれぞれ1.2年と6.3年です。

主要情報

Chris Fair

最高経営責任者

CHF 1.3m

報酬総額

CEO給与比率24.6%
CEO在任期間1.2yrs
CEOの所有権0.4%
経営陣の平均在職期間1.2yrs
取締役会の平均在任期間6.3yrs

経営陣の近況

Shareholders May Find It Hard To Justify Increasing Kuros Biosciences AG's (VTX:KURN) CEO Compensation For Now

Apr 12
Shareholders May Find It Hard To Justify Increasing Kuros Biosciences AG's (VTX:KURN) CEO Compensation For Now

What We Learned About Kuros Biosciences' (VTX:KURN) CEO Pay

Nov 17
What We Learned About Kuros Biosciences' (VTX:KURN) CEO Pay

Recent updates

Kuros Biosciences (VTX:KURN) Is In A Strong Position To Grow Its Business

Nov 28
Kuros Biosciences (VTX:KURN) Is In A Strong Position To Grow Its Business

Kuros Biosciences AG's (VTX:KURN) Shares Climb 30% But Its Business Is Yet to Catch Up

Oct 24
Kuros Biosciences AG's (VTX:KURN) Shares Climb 30% But Its Business Is Yet to Catch Up

Market Participants Recognise Kuros Biosciences AG's (VTX:KURN) Revenues Pushing Shares 37% Higher

Aug 22
Market Participants Recognise Kuros Biosciences AG's (VTX:KURN) Revenues Pushing Shares 37% Higher

We Think Kuros Biosciences (VTX:KURN) Can Afford To Drive Business Growth

Jul 16
We Think Kuros Biosciences (VTX:KURN) Can Afford To Drive Business Growth

Kuros Biosciences AG (VTX:KURN) Stocks Shoot Up 28% But Its P/S Still Looks Reasonable

May 30
Kuros Biosciences AG (VTX:KURN) Stocks Shoot Up 28% But Its P/S Still Looks Reasonable

Why Investors Shouldn't Be Surprised By Kuros Biosciences AG's (VTX:KURN) 35% Share Price Surge

Apr 11
Why Investors Shouldn't Be Surprised By Kuros Biosciences AG's (VTX:KURN) 35% Share Price Surge

Some Confidence Is Lacking In Kuros Biosciences AG (VTX:KURN) As Shares Slide 29%

Jan 03
Some Confidence Is Lacking In Kuros Biosciences AG (VTX:KURN) As Shares Slide 29%

Companies Like Kuros Biosciences (VTX:KURN) Are In A Position To Invest In Growth

Dec 17
Companies Like Kuros Biosciences (VTX:KURN) Are In A Position To Invest In Growth

We Think Kuros Biosciences (VTX:KURN) Can Afford To Drive Business Growth

Sep 17
We Think Kuros Biosciences (VTX:KURN) Can Afford To Drive Business Growth

Market Cool On Kuros Biosciences AG's (VTX:KURN) Revenues

Jun 28
Market Cool On Kuros Biosciences AG's (VTX:KURN) Revenues

Here's Why We're Not At All Concerned With Kuros Biosciences' (VTX:KURN) Cash Burn Situation

May 03
Here's Why We're Not At All Concerned With Kuros Biosciences' (VTX:KURN) Cash Burn Situation

Companies Like Kuros Biosciences (VTX:KURN) Are In A Position To Invest In Growth

Jun 11
Companies Like Kuros Biosciences (VTX:KURN) Are In A Position To Invest In Growth

Shareholders May Find It Hard To Justify Increasing Kuros Biosciences AG's (VTX:KURN) CEO Compensation For Now

Apr 12
Shareholders May Find It Hard To Justify Increasing Kuros Biosciences AG's (VTX:KURN) CEO Compensation For Now

Reflecting on Kuros Biosciences' (VTX:KURN) Share Price Returns Over The Last Five Years

Mar 02
Reflecting on Kuros Biosciences' (VTX:KURN) Share Price Returns Over The Last Five Years

What We Learned About Kuros Biosciences' (VTX:KURN) CEO Pay

Nov 17
What We Learned About Kuros Biosciences' (VTX:KURN) CEO Pay

CEO報酬分析

Kuros Biosciences の収益と比較して、Chris Fair の報酬はどのように変化したか？
日付総報酬給与会社業績
Jun 30 2024n/an/a

-CHF 9m

Mar 31 2024n/an/a

-CHF 11m

Dec 31 2023CHF 1mCHF 329k

-CHF 14m

Sep 30 2023n/an/a

-CHF 15m

Jun 30 2023n/an/a

-CHF 16m

Mar 31 2023n/an/a

-CHF 15m

Dec 31 2022CHF 36kn/a

-CHF 15m

Sep 30 2022n/an/a

-CHF 13m

Jun 30 2022n/an/a

-CHF 11m

Mar 31 2022n/an/a

-CHF 9m

Dec 31 2021CHF 36kn/a

-CHF 8m

報酬と市場: Chrisの 総報酬 ($USD 1.51M ) は、 Swiss市場 ($USD 1.35M ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Chrisの報酬は増加しましたが、会社は利益を上げていません。

CEO（最高経営責任者

Chris Fair (54 yo)

1.2yrs

在職期間

CHF 1,337,700

報酬

Mr. Christopher T. Fair, also known as Chris, serves as the Chief Executive Officer At Kuros Biosciences AG since October 2023 and serves as Director since April 17, 2024. He was the Chief Operating Office...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Christopher Fair
CEO & Director1.2yrsCHF 1.34m0.35%
CHF 2.8m
Daniel Geiger
Chief Financial Officer1.6yrsデータなしデータなし
Sjoerd Musters
COO & GM of BV1.2yrsデータなしデータなし
Joost de Bruijn
President of Innovation and Strategy & Executive Director1.2yrsCHF 873.70kデータなし
G. Ross
Senior Vice President of Marketing & Business Developmentless than a yearデータなしデータなし
Nikki Coleman
Vice President of Global Human Resourcesless than a yearデータなしデータなし
Philippe Saudan
Chief Development Officer8.3yrsデータなしデータなし
John Griffin
Chief Commercial Officer6.7yrsデータなしデータなし
Katherine Sage
Senior Vice President of Medical & Clinical Affairsless than a yearデータなしデータなし
Virginia Jamieson
Consultant6.6yrsデータなしデータなし

1.2yrs

平均在職期間

56yo

平均年齢

経験豊富な経営陣: KURNの経営陣は 経験豊富 とはみなされません ( 1.2年の平均在職年数)。これは新しいチームを示唆しています。

取締役

名称ポジション在職期間報酬所有権
Christopher Fair
CEO & Directorless than a yearCHF 1.34m0.35%
CHF 2.8m
Joost de Bruijn
President of Innovation and Strategy & Executive Director6.5yrsCHF 873.70kデータなし
Clemens van Blitterswijk
Chairman7.5yrsCHF 92.60k1.94%
CHF 15.2m
Oliver Walker
Independent Non-Executive Director6.5yrsCHF 73.80kデータなし
Cato Laurentin
Member of Advisory Boardno dataデータなしデータなし
Ralph Müller
Member of Advisory Boardno dataデータなしデータなし
Norbert Boos
Member of Advisory Boardno dataデータなしデータなし
Thomas Steffen
Member of Advisory Boardno dataデータなしデータなし
Andrew Sama
Member of Strategic Advisory Board6.3yrsデータなしデータなし
Richard Allen
Member of Strategic Advisory Board6.3yrsデータなしデータなし
Alpesh Patel
Member of Strategic Advisory Board6.3yrsデータなしデータなし
Kornelis Poelstra
Member of Strategic Advisory Board6.3yrsデータなしデータなし

6.3yrs

平均在職期間

56.5yo

平均年齢

経験豊富なボード: KURNの 取締役会 は 経験豊富 であると考えられます ( 6.3年の平均在任期間)。